HCPLive Network
Latest Oncology Headlines
Wednesday, October 1, 2014
As director of the Yale Cancer Center and physician-in-chief of the Smilow Cancer Hospital at Yale-New Haven, Thomas J. Lynch Jr, MD, wears many hats. And, having built a career united around two abiding goals of clinical discovery and personalized patient care, that’s just the way he likes it.
Wednesday, October 1, 2014
Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer, according to research published online Sept. 29 in the Journal of Clinical Oncology. The finding didn't speak to the risk of CRC recurrence, only the potential for developing other cancers associated with obesity.
Wednesday, October 1, 2014
Newly approved anticancer drugs that do not have a specific molecular target on cancer cells are associated with increased toxicity and the accompanying costs of management, according to research published online Sept. 29 in the Journal of Clinical Oncology.
Wednesday, October 1, 2014
Work, non-work, and individual factors explain a considerable part of psychological distress, depression, and emotional exhaustion, according to a study published online July 24 in Social Psychiatry and Psychiatric Epidemiology.
Wednesday, October 1, 2014
Michael J. Hennessy Associates‚ Inc (MJH), a full-service healthcare education, market research, and communications company reaching more than 600,000 healthcare professionals, has acquired CURE Media Group (www.curetoday.com) from McKesson Specialty Health, a division of McKesson Corporation.
Wednesday, October 1, 2014
A study in rats hints that exposure to dim light at night may make human breast cancer tumors resistant to doxorubicin. The study was presented at the American Association for Cancer Research's International Conference on Frontiers in Cancer Prevention Research, held from Sept. 28 to Oct. 1 in New Orleans.
Wednesday, October 1, 2014
By Maurie Markman, MD
One of the most striking changes in our understanding of the fundamental biology of malignant disease has been the observation that “driver” molecular abnormalities may frequently cross major histologic barriers.
Wednesday, October 1, 2014
The risk of medical professional liability claims alleging failure to screen for esophageal cancer is not a reason to screen for esophageal cancer, according to a research letter published in the Oct. 1 issue of the Journal of the American Medical Association.
Tuesday, September 30, 2014
Adding the drug pertuzumab (Perjeta) to trastuzumab may give women with human epidermal growth factor receptor 2-positive metastatic breast cancer a boost in survival, according to new research presented Sunday at the annual meeting of the European Society of Medical Oncology, held from Sept. 26 to 29 in Madrid.
Tuesday, September 30, 2014
Obesity and inflammation in late adolescence are associated with increased risk for colon and rectal cancer in adulthood, according to a study presented at the American Association for Cancer Research's International Conference on Frontiers in Cancer Prevention Research, held from Sept. 28 to Oct. 1 in New Orleans.
Tuesday, September 30, 2014
Having trainee physicians review cases prior to clinic hours can reduce patient waiting times, flow times, and clinic session times, according to a study published online Sept. 16 in Pain Medicine. The management process studied was first popularized by Toyota in Japan.
Monday, September 29, 2014
Personal health is a global concern and 3 initiatives are being developed to encourage positive change, according to a report from the American Medical Association.
Monday, September 29, 2014
People derive value from the anticipation of purchasing something, and this anticipation tends to be greater for an experiential purchase than for a material purchase, according to a study published online Aug. 21 in Psychological Science.
Friday, September 26, 2014
By Silas Inman
The FDA has assigned a priority review designation to the PD-1 inhibitor nivolumab (Opdivo) as a treatment for pretreated patients with advanced melanoma.
Friday, September 26, 2014
For more than 20 years, Klaus Strebhardt, PhD, has been exploring the polo-like kinase (PLK) pathway, including its role in cancer and Plk1-targeted anticancer therapies.
Friday, September 26, 2014
By Joseph Burns
In July, UnitedHealthcare (UHC) reported that an innovative program using bundled payment for cancer care resulted in an impressive 34% reduction in medical costs when compared with costs for a control group
Thursday, September 25, 2014
By Jane de Lartigue, PhD
The concept of targeting mitotic cell division to halt the progression of rapidly dividing cancer cells has long been a staple of oncology therapy, yet chemotherapy agents that are the prime examples of this approach are nonselective in their action and can kill normal and malignant cells alike.
Thursday, September 25, 2014
By Beth Fand Incollingo
The rate of severe urinary tract infections following transrectal ultrasound-guided biopsy for the detection of prostate cancer has been on the rise in Sweden
Wednesday, September 24, 2014
By Silas Inman
The combination of ABT-199 and ibrutinib (Imbruvica) demonstrated promising early activity in mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) cell lines
Wednesday, September 24, 2014
By Beth Fand Incollingo
If a man has a certain pattern of baldness when he reaches 45 years of age, he faces a 45% higher risk of developing aggressive prostate cancer later in life than does a man with no baldness at that age.
Physician's Money Digest
The cost of becoming a capable doctor (one who does both well and good) can come at a great price. Lay folk think it’s just all rich doctors out there. But those physicians who stick around can dig a real big financial hole for themselves.
The Centers for Medicare and Medicaid Services on Tuesday published a cache of physician payment data covering the last five months of 2013. The data is vast, but an early look at the site shows it has strengths and weaknesses.